Compulsory detention as drug treatment and the impact on HIV outcomes A Kamarulzaman University of Malaya, Kuala Lumpur, Malaysia.

Slides:



Advertisements
Similar presentations
Supporting community action on AIDS in developing countries Supporting community action on AIDS in India Children Affected By AIDS in Low and Concentrated.
Advertisements

CURE & CARE. Treatment Scenario in Malaysia Compulsory Treatment Provided for drug dependants since 1983 Drug Rehabilitation Centers (DRC) & Supervision.
Saving lives, changing minds. Collaborative TB/HIV services for people who use drugs The experience of Red Cross / Red Crescent Lasha Goguadze.
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
The Alcohol and Drug Abuse Administration State Care Coordination 1.
Combined prevention programs within criminal justice systems – examples from Malaysia A Kamarulzaman, S Kaur, MN Nazar, M Azahari, C Koh, H AlDarraji,
GAP Report 2014 Sex workers People left behind: Sex workers Link with the pdf, Sex workers.
Rolling Out The National Harm Reduction Programme in Malaysia
Supporting community action on AIDS in developing countries MDG’s and the Law: Creating an Enabling Legislative Environment Anton Kerr Head of Policy –
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
Testing for key populations – from the perspectives of those living with HIV Ed Ngoksin Global Network of People Living with HIV (GNP+)
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Annabel Baddeley Global TB Programme WHO, Geneva
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
TRANSFORMATION JOURNEY OF TREATMENT AND REHABILITATION
Overlapping risks, overwhelming barriers: addressing HIV risk among adolescents selling sex in Asia and the Pacific Himakshi Piplani HIV.
Psychiatric Mental Health Nursing in Acute Care Settings.
Drug Detention in China and Cambodia Acknowledgements: Joseph Amon, Rebecca Schleifer and colleagues Health & Human Rights Division Human Rights Watch.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Community Paralegals Developing Peer Legal Support for People Who Use Drugs in Indonesia Bridging the Gaps Indonesian Drug Users Network (PKNI)
Part 2 Gender and HIV/AIDS HIV/AIDS IS A GENDER ISSUE BECAUSE: I Although HIV effects both men and women, women are more vulnerable because of biological,
EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.
Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users Hans Blystad 1 and.
Kazakhstan Gulnara Darbekova (1), Nadezhda Kozachenko (1), Irina Mingazova (1), Alexander Solodov (1), Natalia Kartashova (1), Zita Lazzarini (2,3), Patricia.
Dr Pamela Smith – Fall  Definition = development of resources necessary to provide mental health care within a given setting or community  Function.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
ILLINOIS STATEWIDE TREATMENT OUTCOMES PROJECT. Illinois Statewide Treatment Outcomes Project Largest evaluation of treatment outcomes by the State to.
Alcohol And Drug Abuse Issues Volusia And Flagler Counties Stewart-Marchman Center, Inc. July 2006.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Treatment 101 Substance Abuse Basics West Coast Consulting Wanda King
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
Principles of Drug Addiction Treatment (Section 5 continued…) UCLA Integrated Substance Abuse Programs Continuum of Care 1.
OPIOID SUBSTITUTION THERAPY
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
1 Psychosocial Issues Faced by PLHIV HAIVN Harvard Medical School AIDS Initiative in Vietnam.
TTK’s experience in community care Designated by the UNODC as a Learning Centre for Low Cost Community Care Have been conducting alcoholism treatment.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Delivery Systems for Substance Abuse Treatment: THE HASHEMITE KINGDOM OF JORDAN Dr. Jamal Anani Director of National Centre for Rehabilitation of Addicts.
1 Kennedy Roberts Senior Medical Officer and Clinical Lead North Cluster Glasgow Addiction Services Community Addiction Teams What are the challenges for.
Research Proposal John Miller Nicolette Edenburn Carolyn Cox.
Washington D.C., USA, July 2012www.aids2012.org Condoms as evidence Susan Timberlake Chief, Human Rights and Law Division UNAIDS Secretariat Geneva.
Ester Wina 24 July th IAC, Melbourne, Australia.
Addiction Treatment in Israel: An Overview of Services Provision Iris Mordecovitch, MSW.
Group work, people who inject drugs, TB and HIV Maldives, Malaysia, Bangladesh 2, Philippines, Bhutan, PNG, Cambodia, Thailand and Viet Nam.
Project RAS/H13 “Prevention of transmission of HIV among drug users in SAARC Countries” Lubna Mohamed Zahir Hussain Chairperson of National Drug Agency.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
The impact of community-based drug and alcohol treatment on reoffending in Indigenous communities Anthony Morgan, Tracy Cussen, Alex Gannoni & Jason Payne.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Factors associated with concurrent Heroin use among patients on Methadone maintenance treatment in Vietnam from 2008 to 2013 Hoang Nam Thai MD, MPH – CDC/DGHT.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Overcoming the Challenges of Providing HIV Prevention and Treatment Services for People Who Inject.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
…Implications for Wales Josie Smith Programme Lead for Substance Misuse, Public Health Wales TOWARDS A HEALTH BASED APPROACH.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
Substance Exposed Newborns: Addressing Substance Use Disorder
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Medication-Assisted Therapy at Coleman Profession Services
Current harm reduction program at outreach
Harm reduction: decriminalising drug use in Asia
Here Is Some More About Drug Addiction Treatment
Nick Szubiak, MSW, LCSW Director, Clinical Excellence in Addictions
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
The Judicial Branch’s Response to the Opioid Crisis
Can be personalized to individual group needs.
Presentation transcript:

Compulsory detention as drug treatment and the impact on HIV outcomes A Kamarulzaman University of Malaya, Kuala Lumpur, Malaysia

Over 1,000 compulsory centres across Asia Myanmar, Cambodia, China, Laos, Malaysia, Thailand, and Vietnam An estimated 400,000 PWUD detained in CCDU No of detainees range from 2000 – depending on country Duration of detention – varies from country to country

Administered through criminal or administrative law Operated by variety of institutions – law enforcement authorities – judiciary – local/municipal authorities – Ministry of Health and the Ministry of Social Affairs Admission typically extrajudicial, without due legal process Detained in police sweeps, single positive urine test, turned over by family or community members.

Treatment of Substance Use Substance use disorders highly prevalent Treatment - largely based on abstinence Rarely have trained professionals or medical staff Relapse rates – 70% or more

Gruelling physical exercises Military style training Physical abuse and torture Denial of or inadequate provision of medical care Forced work regimens set within an abusive environment Variety of human rights abuses

Prevention and Treatment of HIV Data on HIV and HCV prevalence scarce No access to treatment for HIV and comorbidities Lack of financial resource Lack of trained staff General negative attitude towards PWUD

Prevention and Treatment of HIV Mandatory HIV testing common Detainees often not told of results No linkages to care No assessment of CD4

July – August Centres, 6,658 detainees 100 HIV +ve detainees in 2 Centres 70% from rural area Mean of 3.0 cumulative detentions in prison, 2.3 in CCDU 90 minute survey MINI, DAST-10, PHQ-9, TB symptom screening algorithm Sept 2012

95% met DSM-IV criteria for opioid dependence 93% reported substantial or high addiction severity prior to detention. 95% injected drugs in the 30 days prior to detention 65% reported daily heroin injection 22% reported daily injection of multiple substances

Life Time Use Alcohol92 Heroin99 Buprenophrine47 Benzodiazepine55 ATS89 Ketamine21 Cannabis81 Multiple substances91

78% had been diagnosed with HIV – 20% during this detention Mean time since HIV diagnosis years 9% had received any HIV-related clinical assessment or care No access to ARV 34% had ever been CD4 tested – 18% had ever received a CD4 test result Median CD4 count cells/mL (range 15–1025 cells/mL) ¾ were on ARV 30 days prior to detention - forced to discontinue treatment due to its unavailability in the detention facility

23% screened positive for symptoms indicative of active tuberculosis – based on a screening algorithm (sensitivity 93%; specificity 36%) – prolonged cough (65%), fever (56%) and night sweats (30%) 14% had suicidal ideation over the previous two weeks.

In-depth and key informant interviews 19 PWID, 20 government and NGO officials Average drug use 14 y (range 8–23 y) Detox 4 times (range 1-8 times) Intense fear of being recognized by the police and being detained Routine HIV testing without consent and without disclosure of the result HIV-infected detainees were not routinely provided medical or drug dependency treatment IDUs received little or no information or means of HIV prevention Dec 2008

The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand 435 IDU 111 (25.5%) reported avoiding healthcare Avoiding healthcare associated with – exposure to compulsory drug detention (adjusted prevalence ratio [APR] = 1.60; 95% [CI]: 1.16–2.21), – having been refused healthcare (APR = 3.46; 95% CI: 2.61–4.60), – experiencing shame associated with one’s drug use (APR = 1.93; 95% CI: 1.21–3.09). IJDP 2014

Evolving response

Transformation of Compulsory Drug Detention Centers into Voluntary Evidence Based Treatment & Care Centers - Malaysia

CONCEPT OPEN ACCESS SERVICES Voluntarism or Walk-in Support from parents or family Referral Outreach / Motivate No Legal Implications No Pre-conditions No stigma Private and Confidential Options for clients Community-based Program Clients as patients

COMPULSORY DRUG REHAB. CENTERS  C&C CLINIC Compulsory Treatment & Admission through the Law; Criminal Records; Stigma Focus on medical, psychiatric & clinical treatment Treatment- psychosocial based services only Focus on medical, psychiatric & clinical treatment Treatment for all substance abusers (opiate, ATS, inhalant) – males, females & adolescent are separated Treatment Duration – 2 years Treatment duration – 1-3 months (inpatient), 4-6 months (outpatient) Capacity for residents in DRCs – 7,350 Number of clients that accessed services at 8 C&C Clinics – 9,041 Cost of food – RM8.00 x 30 days x 12 months /person = RM 2,880 Cost of food – RM8.00 x 30 x 3 months = RM (able to treat 4x more no patients) Loss of Property caused by violence, arsonNo incidence of violence or arson

C&C 1MALAYSIA (C&C) & CURE&CARE REHAB CENTER (CCRC) Malaysia yEARCCRC-Legal sanction (sek.6(1)(a) No of detainees C&C- Voluntary Cure & Care Centres No of clients ,7899, ,47312, ,13614,426 TotaL 15,39836, CCDU HAVE BEEN CONVERTED TO CURE & CARE CLINICS WITH REMAINING 18 STILL FUCTIONING CURRENTLY 6,500 CLIENTS ARE RECEIVING METHADONE AT ALL THESE VOLUTARY CENTRES

56.3% Helped maintain jobs 42.7% Helped get into government support services 54.3% Continued education 77.6% Improved family relations 72.1% Obtained permanent homes 75.9% Prevented arrest into prisons OUTCOME EVALUATION AT C&C CLINIC

73.8% Prevented admission into Compulsory DRCs 78.3% Helped family or friends to get treatment and rehabilitation 76.7% Access to medical care 94.9% Very satisfied with the methadone maintenance programme 94.4% Reduced drug cravings 65.4% Obtained skill training OUTCOME EVALUATION AT C&C CLINIC

“This significant change in policy signals a new sense of urgency. As drug dependency is a health issue that should be treated medically, there is a need to take a bolder but softer approach rather than a punitive one………. This is why efforts must be stepped up to decriminalise drug dependency, actively address the issue of the stigma of addiction………………………. NST March 2011

Challenges in moving towards a voluntary community-based treatment centres a.Laws of several countries providing for detention of people who use drugs in CCDUs; b.Stigma and discrimination c.Limited technical capacity for voluntary community-based drug treatment d.Imbalances between investments in supply and demand reduction

Key Recommendations Reviews of laws, policies and practices Reallocate human and financial resources from CCDUs to voluntary community-based treatment Mobilise additional human resources, including involvement of affected population Build capacity through specialized training for the delivery of voluntary community-based services.